已收盘 07-26 16:00:00 美东时间
+0.230
+0.67%
Morgan Stanley analyst Brian Nowak maintains Maplebear (NASDAQ:CART) with a Equal-Weight and raises the price target from $43 to $45.
07-24 01:25
中国最优秀的CAR-T资产正在“流失”,我们正在失去对于CAR-T疗法未来的议价权。 7月12日,传奇生物被曝收到并购邀约,并计划聘请投资银行Centervi...
07-17 07:28
Wolfe Research initiated coverage on 22 large and small/mid-cap internet names, singling out several for the opportunity for growth thanks to generative artificial intelligence (GenAI), and others tha...
07-16 21:47
转自:氨基观察 近日,华尔街传来消息,传奇生物收到了收购要约。 据《华尔街内幕》报道,传奇生物已聘请顶尖投行Centerview Partners协助董事会审查...
07-15 19:57
Amazon (NASDAQ:AMZN) has released its generative artificial intelligence-powered shopping assistant dubbed Rufus to all U.S. consumers using the Amazon Shopping app, the company announced Friday. Rufu...
07-12 22:36
Keybanc analyst Justin Patterson initiates coverage on Maplebear (NASDAQ:CART) with a Sector Weight rating.
07-11 17:36
Immix Biopharma (NASDAQ:IMMX) on Monday announced that the first patient had been dosed in its U.S. NEXICART-2 trial with NXC-201. The company added that the timing of the milestone was in-line with i...
07-09 02:04
In the last week, Johnson and Johnson announced positive results from two clinical trials and authorization from Health Canada for RYBREVANT in combination with platinum-based chemotherapy.
07-05 22:35
金斯瑞生物科技(01548)早盘逆市上涨2.49%,现报9.07港元,成交额5187.45万港元。 传奇生物于7月2日宣布,其CARVYKTI(cilta...
07-05 11:35
7月3日,强生(JNJ.US)与传奇生物(LEGN.US)共同宣布了3期CARTITUDE-4研究预定第二次中期分析的积极结果。
07-03 10:03